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Abstract
Background: Apoptosis plays a key role in cell death observed in neurodegenerative diseases
marked by a progressive loss of neurons as seen in Alzheimer's disease. Although the exact cause
of apoptosis is not known, a number of factors such as free radicals, insufficient levels of nerve
growth factors and excessive levels of glutamate have been implicated. We and others, have
previously reported that in a stable HT22 neuronal cell line, glutamate induces apoptosis as
indicated by DNA fragmentation and up- and down-regulation of Bax (pro-apoptotic), and Bcl-2
(anti-apoptotic) genes respectively. Furthermore, these changes were reversed/inhibited by
estrogens. Several lines of evidence also indicate that a family of cysteine proteases (caspases)
appear to play a critical role in neuronal apoptosis. The purpose of the present study is to
determine in primary cultures of cortical cells, if glutamate-induced neuronal apoptosis and its
inhibition by estrogens involve changes in caspase-3 protease and whether this process is mediated
by Fas receptor and/or mitochondrial signal transduction pathways involving release of cytochrome
c.
Results: In primary cultures of rat cortical cells, glutamate induced apoptosis that was associated
with enhanced DNA fragmentation, morphological changes, and up-regulation of pro-caspase-3.
Exposure of cortical cells to glutamate resulted in a time-dependent cell death and an increase in
caspase-3 protein levels. Although the increase in caspase-3 levels was evident after 3 h, cell death
was only significantly increased after 6 h. Treatment of cells for 6 h with 1 to 20 mM glutamate
resulted in a 35 to 45% cell death that was associated with a 45 to 65% increase in the expression
of caspase-3 protein. Pretreatment with caspase-3-protease inhibitor z-DEVD or pan-caspase
inhibitor z-VAD significantly decreased glutamate-induced cell death of cortical cells. Exposure of
cells to glutamate for 6 h in the presence or absence of 17β -estradiol or ∆ 8, 17β -estradiol (10 nM-
10  µM) resulted in the prevention of cell death and was associated with a significant dose-
dependent decrease in caspase-3 protein levels, with ∆ 8, 17β -E2 being more potent than 17β -E2.
Protein levels of Fas receptor remained unchanged in the presence of glutamate. In contrast,
treatment with glutamate induced, in a time-dependent manner, the release of cytochrome c into
the cytosol. Cytosolic cytochrome c increased as early as 1.5 h after glutamate treatment and these
levels were 5 fold higher after 6 h, compared to levels in the untreated cells. Concomitant with
these changes, the levels of cytochrome c in mitochondria decreased significantly. Both 17β -E2 and
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∆ 8, 17β -E2 reduced the release of cytochrome c from mitochondria into the cytosol and this
decrease in cytosolic cytochrome c was associated with inhibition of glutamate-induced cell death.
Conclusion: In the primary cortical cells, glutamate-induced apoptosis is accompanied by up-
regulation of caspase-3 and its activity is blocked by caspase protease inhibitors. These effects of
glutamate on caspase-3 appear to be independent of changes in Fas receptor, but are associated
with the rapid release of mitochondrial cytochrome c, which precedes changes in caspase-3 protein
levels leading to apoptotic cell death. This process was differentially inhibited by estrogens with the
novel equine estrogen ∆ 8, 17β -E2 being more potent than 17β -E2. To our knowledge, this is the first
study to demonstrate that equine estrogens can prevent glutamate-induced translocation of
cytochrome c from mitochondria to cytosol in rat primary cortical cells.
Background
High concentrations (mM) of the excitatory neurotrans-
mitter glutamate can accumulate in the brain and are
thought to be involved in the etiology of a number of neu-
rodegenerative disorders including Alzheimer's disease [1-
4]. A number of in vitro studies indicate that at high con-
centrations, glutamate is a potent neurotoxin capable of
destroying neurons [5,6].
The mechanisms by which glutamate-induced neurotoxic-
ity or excitotoxicity is mediated, has not been established,
however, a substantial body of evidence suggests that
glutamate toxicity involves oxidative stress and apoptosis
(programmed cell death) [2,7-9]. This latter form of cell
death is characterized by DNA degradation that results by
cleaving DNA at internucleosomal sites [10]. Apoptosis is
a gene-directed process and an increasing number of
genes and their proteins are involved in this process
[11,12]. We have previously reported that in a stable
mouse hippocampal neuronal cell line (HT22), gluta-
mate-induced cell death is associated with DNA fragmen-
tation and up-regulation of the pro-apoptotic protein Bax
and down-regulation of the anti-apoptotic protein Bcl-2,
however, in this cell line, the apoptotic process did not
appear to involve caspase-3 [13]. In contrast, recent stud-
ies demonstrate that a family of cysteine proteases (cas-
pases) play an important role in apoptotic cell death
observed in some neurodegenerative diseases [14-16].
Caspase-3 is considered to be the central and final apop-
totic effector enzyme responsible for many of the biologi-
cal and morphological features of apoptosis [15-17].
Caspase-3 usually exists in the cytosolic fraction of cells as
an inactive precursor that is activated proteolytically by
cleavage at a specific amino acid sequence to form the
active enzyme [18] which is capable of cleaving several
proteins that culminate in apoptotic cell death [19].
Although these observations strongly indicate that cas-
pase-3 is essential for apoptosis in mammalian cells, the
mechanisms involved in caspase-3 regulation of the neu-
ronal system remain to be elucidated. Many signal trans-
duction pathways such as Fas receptor-mediated signaling
pathway via caspase-8, via activation of granzyme B, or
the damage of mitochondria that results in cytochrome c
release, have been implicated in the initiation of caspase-
3 cascade [20-25].
A number of studies have demonstrated that estrogens are
potent antioxidants capable of inhibiting some of the
neurotoxic effects of oxidative stress [7,26,27]. We, and
others have shown that estrogens can increase cell survival
and attenuate in vitro cell death induced by various neuro-
toxins [28-31]. We have also previously demonstrated in
HT22 cells and in the neuronal-like PC12 cell line derived
from rat adrenal pheochromocytoma cells that the neuro-
toxic effects of glutamate can be inhibited differentially by
various equine estrogens [31]. The data further indicated
that the less estrogenic (uterotropic) ∆ 8-estrogens were the
most effective neuroprotectors [31]. We further suggested
that the increased potency of these ∆ 8-estrogens may to
some extent, be due to their greater antioxidant properties
[28,29,31]. However, the mechanism(s) involved in
estrogen mediated neuroprotection are not fully under-
stood. In the present study, we have determined whether
glutamate-induced neuronal apoptosis in primary cortical
cells and its inhibition by estrogen, involves changes in
caspase-3 protease and whether this process is mediated
by Fas receptor and/or mitochondrial signal transduction
pathways involving release of cytochrome c. The estrogens
selected for this study were 17β -estradiol (17β -E2) which
has high affinity for both estrogen receptors ERα  and ERβ
and ∆ 8, 17β -estradiol (∆ 8, 17β -E2), an estrogen that is a
more potent antioxidant than 17β -E2 and whose activity
appears to be mediated to a greater extent via ERβ  [31-34].
Results
Effects of various concentrations of glutamate on cortical 
cell viability
Cortical cells (2.5 × 104) cultured for 7 days in 96-well
plates were treated with increasing concentrations (0.2 –
100 mM) of glutamate for 18 h. As depicted in Figure 1,
increasing concentrations of glutamate resulted in a dose-
dependent decrease in cell viability measured by the MTS
(3-[4,5-dimethylthiazol-2 yl]-5 [3 carboxymethoxyphe-
nyl] 2 H-tetrazolium, inner salt) cell proliferation assay asBMC Neuroscience 2005, 6:13 http://www.biomedcentral.com/1471-2202/6/13
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described under "Methods". Generally as the amount of
glutamate increased, cell death increased progressively,
however, there was no significant difference between 1
and 25 mM glutamate in 18 h. Similar results were
obtained after treatment with glutamate for 6 h (data not
shown). Based on these preliminary data, all subsequent
experiments were carried out for 6 h at glutamate concen-
trations between 1 to 20 mM. At these concentrations, the
mean percent cell death was approximately 20%.
Demonstration of apoptosis in cortical cells treated with 
glutamate
Cortical cells cultured in poly-lysine coated 6-well plates
for up to 7 days were treated with 1 mM glutamate for 18
h. DNA was extracted, purified and subjected to agarose
gel electrophoresis as described under "Methods". The
results indicate (Figure 2), that in DNA isolated from
untreated cortical cells prior to culture (Figure 2, lane 2),
untreated cells in culture for 1 day (Figure 2, lane 3) no
DNA fragmentation was detectable. However, after 2 and
7 days in culture, DNA fragmentation was detectable (Fig-
ure 2, lanes 4 and 6). The extent of DNA fragmentation
was potentiated in cells treated for 18 h with 1 mM gluta-
mate (Figure 2, lanes 5 and 7). These results indicate that
cortical cells in culture for longer than 2 days display char-
acteristic DNA fragmentation or laddering that is associ-
ated with apoptosis mediated via caspase-3 activation.
Glutamate treatment as can be seen in Figure 2, lane 7
induced a much greater DNA fragmentation than
untreated cortical cells. However, these are qualitative
data and should be interpreted with caution, particularly
since some DNA fragmentation occurs in untreated cells.
Glutamate-induced enhancement of apoptosis was also
detectable by characteristic morphological changes
observed by using phase contrast microscopy (Figure 3).
After 6 h in culture, untreated cortical cells retained nor-
mal morphology of neuronal cortical cells and their cellu-
lar extensions (dendrites) and membranes were clearly
visible. An occasional degenerated cell was also visible
(Figure 3A). In contrast, after a 6 h incubation with 1 mM
Effects of various concentrations of glutamate on cell viability Figure 1
Effects of various concentrations of glutamate on cell viability. Primary cortical cells isolated from 18–20 day old fetal 
rat brains were cultured for 7 days and then treated with various concentrations of glutamate or in absence of glutamate (con-
trol) for 18 h. Cell viability was determined using the MTS cell proliferation assay as described under "Methods". Cell viability is 
expressed as the mean (± SEM) from three experiments. * P < 0.05 (1-100 mM)compared with untreated control cells.
* * *
*
*
*
0
20
40
60
80
100
120
control 0.2 1 10 25 50 75 100
Glutamate (mM)
C
e
l
l
 
V
i
a
b
i
l
i
t
y
 
(
%
 
C
o
n
t
r
o
l
)BMC Neuroscience 2005, 6:13 http://www.biomedcentral.com/1471-2202/6/13
Page 4 of 23
(page number not for citation purposes)
Detection of glutamate induced DNA fragmentation (DNA ladder) Figure 2
Detection of glutamate induced DNA fragmentation (DNA ladder) Primary cortical cells isolated from 18–20 day old 
fetal rat brains were cultured for 7 days and treated with 1 mM glutamate for 18 h. The cells were processed as described 
under "Methods". The isolated DNA was electrophoresed on TBE agarose gel for 1.5 h at 100 V. The DNA fragments were 
visualized by staining with ethidium bromide. Lane 1 = 1 kb DNA ladder; lane 2 = DNA from untreated cortical cells prior to 
culture; lane 3 = DNA from untreated control cells cultured for 1 day; lane 4 = DNA from untreated control cells cultured for 
2 days; lane 5 = DNA from cells cultured for 2 days and treated with glutamate for 18 h; lane 6 = DNA from untreated control 
cells cultured for 7 days; lane 7 = DNA from cells cultured for 7 days and then treated for 18 h with glutamate. Note the 
potentiation of DNA fragmentation in presence of glutamate.
LanesBMC Neuroscience 2005, 6:13 http://www.biomedcentral.com/1471-2202/6/13
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glutamate degenerated, dead or apoptotic cells were
clearly visible in these cultures (Figure 3B), and the
cellular extensions seen in untreated cortical cells (Figure
3A), were retracted, and cells appeared rounded. Similar
changes were also observed with 5 mM glutamate (data
not shown). In the presence of 1 mM glutamate and 1 µM,
17β -E2 (Figure 3C) and ∆ 8, 17β -E2 (Figure 3D), the cells
retained the normal morphology of untreated cells, and
only an occasional degenerated cell was visible. These
results clearly confirm that glutamate induces and
enhances apoptosis. These morphological changes and
cell death were prevented by both estrogens. Taken
Glutamate-induced toxicity in rat primary cortical cells as assessed by phase contrast microscopy (100×) Figure 3
Glutamate-induced toxicity in rat primary cortical cells as assessed by phase contrast microscopy (100×). Pri-
mary cortical cells isolated from 19 day old fetal rat brains were cultured for 7 days and then treated with 1 mM glutamate 
alone or in the presence of estrogens for 6 h. Degenerated cells are depicted by arrowheads. A = untreated control cells; B = 
cells treated with 1 mM glutamate for 6 h; C = cells treated with 1 mM glutamate and 1 µM 17β -E2; D = cells treated with 1 
mM glutamate and 1 µM ∆ 8, 17β -E2. Note after glutamate treatment, dead cells with loss of dendrites are clearly visible in the 
cultures. In contrast, either untreated control cells or cells treated with glutamate in presence of estrogens retain their normal 
morphology. Dendrites and membranes are clearly visible and only a few degenerated cells are present in these cultures 
(A,C,D).
A
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together, these data indicate that cortical cells in the pres-
ence of glutamate undergo apoptotic changes in culture.
Effects of glutamate and estrogens on cell death
Cortical cells were cultured in 6-well plates (1 × 106 cells/
well) for 7 days. The medium was then changed and the
effects of various concentrations (1–20 mM) of glutamate
on lactate dehydrogenase (LDH) release were measured
for 6 h. The results indicate that glutamate induced a sig-
nificant (30–40%) increase in LDH release compared to
the control untreated cells. No significant difference in
LDH release was observed in 6 h at glutamate concentra-
tion between 1 to 20 mM, (data not shown). Based on
these observations and the cell viability data (Figure 1), all
subsequent experiments were done in the presence of 1 or
5 mM glutamate to avoid potential necrosis which may
occur at higher concentration of glutamate. In order to fol-
low the kinetics of glutamate cytotoxicity, the effect of 5
mM glutamate on LDH release as a function of time was
measured for up to 24 h. The results shown in Figure 4
indicate that glutamate toxicity varied markedly during
the course of culture. Significant increase (40–60%) in
cytotoxicity was observed after 6 to 24 h exposure of cells
to glutamate. During this period, LDH release in
untreated control cells remained the same for up to 8 h
and significantly increased (P < 0.05) after 24 h (Figure 4).
Next, cortical cells were treated with 5 mM glutamate for
6 h in the presence or absence of various concentrations
(0.01–10 µM) of 17β -E2 and ∆ 8, 17β -E2. Release of LDH
from cells was measured and the results are summarized
in Figure 5. Both 17β -E2 and ∆ 8, 17β -E2 inhibited gluta-
mate-induced cell death in a dose-dependent manner,
with ∆ 8, 17β -E2 being more potent. Thus, 0.1 µM ∆ 8, 17β -
E2 and 1 µM 17β -E2 significantly reduced cell death com-
pared to glutamate alone (Figure 5). However, even at the
highest concentration of estrogens tested, cell death
induced by 5 mM glutamate was not fully preventable. In
contrast, when cell death was induced by lower concentra-
tion (1 mM) of glutamate, 10 µM of ∆ 8, 17β -E2 completely
inhibited cell death and the release of LDH returned to
control levels (data not shown).
Effects of glutamate and estrogens on caspase-3 protein 
levels
Following measurement of LDH, cortical cells were har-
vested, lysed and processed for Western blot analysis as
described under "Methods". The results (Figure 6) indi-
cate that both anti-caspase-3 antibodies detected the pres-
ence of caspase-3 Mr 32 kDa protein band (precursor
protein), but not the p 20 and p 11 active fragments of cas-
pase-3. The results further indicate that the exposure of
cells to glutamate resulted in an increase in caspase-3 pre-
cursor protein in a dose (Figure 6) and time (Figure 7),
dependent manner. Thus, 1 to 5 mM glutamate increased
caspase-3 protein levels by 45 to 66% respectively, how-
ever, higher concentrations of glutamate (10–20 mM) did
not result in any further increase in caspase-3 protein lev-
els (Figure 6). The kinetics of glutamate effects on caspase-
3 protein levels indicate that a significant increase in the
levels occurred by 3 h of glutamate (5 mM) exposure and
reached maximum levels observed at 6 h (54% increase)
(Figure 7). The levels were significantly lower at 24 h (Fig-
ure 7), most likely due to decreased transcription of cas-
pase-3. These results further indicate that changes in levels
of caspase-3 occur soon after induction of apoptosis. Lack
of further increase in caspase-3 protein levels suggest that
cell death at this late stage may be due to necrosis and
therefore all subsequent experiments were carried out for
up to 6 h only. These glutamate-induced changes were
reversed in the presence of estrogens. Thus, increasing
concentrations of 17β -E2 and ∆ 8, 17β -E2 in the presence of
5 mM glutamate for 6 h resulted in a decrease in caspase-
3 levels in a dose-dependent manner (Figure 8). As
depicted in Figure 8, glutamate (5 mM) alone increased
the levels of caspase-3 by 60% and in the presence of 1 to
10 µM 17β -E2, the levels of caspase-3 protein decreased
gradually and returned to control values with 10 µM 17β -
E2. Similar results were obtained with ∆ 8, 17β -E2, how-
ever, significant decrease (30%) in the levels of caspase-3
occurred at 10 times lower concentration (1 µM) (Figure
8). When cell death was induced with lower concentration
(1 mM) of glutamate, 0.1 µM 17β -E2 and ∆ 8, 17β -E2 com-
pletely inhibited the changes in caspase-3 protein and the
levels returned to control values (Figure 9). Whether the
ability of low concentrations of estrogens to fully protect
the cortical cells against neurotoxicity induced by 1 mM
glutamate was due to the cell death resulting via predom-
inantly apoptosis rather than necrosis or a mixture of the
two processes remains to be investigated.
Effects of caspase inhibitors, z-DEVD and z-VAD, on 
glutamate-induced cell death
To further confirm the role of caspase-3 in glutamate-
induced cell death, cortical cells were pre-incubated with
100 µM of z-DEVD or z-VAD prior to induction of cell
death by 1 mM glutamate. Glutamate alone caused a sig-
nificant increase in cell death over control (Figures 10 A,
B), while pre-incubation with the caspase-3 inhibitors
prior to glutamate exposure resulted in a 50% reduction
in cell death (Figures 10 C, D). In absence of glutamate,
both inhibitors had no effect on cell viability (Figures 10
E, F). Similarly, DMSO, the vehicle used in the prepara-
tion of the inhibitors had no effect on cell viability (Figure
10 G). These data confirm that in primary culture of rat
cortical cells glutamate induces cell death via the apop-
totic pathway that involves changes in caspase-3 protease.BMC Neuroscience 2005, 6:13 http://www.biomedcentral.com/1471-2202/6/13
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Activation of caspase-3
(a) Effects of caspase inhibitors on proleolytic cleavage of protein 
kinase c (PKC) in untreated primary cortical cells and cells treated 
with glutamate
During apoptosis, activation of caspases including cas-
pase-3 can result in the generation of breakdown products
(BDPs) of PKC [35,36]. Primary cortical cells were either
treated with glutamate alone or first pretreated with cas-
pase-3 specific inhibitor z-DEVD or pan-caspase inhibitor
z-VAD as described under "Methods". The immunoblots
are depicted in Figure 11. Glutamate treatment resulted in
an increase in the formation of two BDPs (48 kDa and 45
kDa) in both the cytosol and cell lysates. Pretreatment
with z-DEVD and z-VAD reduced the amounts of the two
BDPs to levels seen in the untreated primary cortical cells
(Figure 11). These results clearly indicate that pro-caspase-
3 is activated and that active caspase-3 is present in pri-
mary cortical cells and cells treated with glutamate.
(b) Detection of active caspase-3 in primary cortical cells treated with 
glutamate
Western blot analysis had indicated the presence of pro-
caspase-3 in primary cortical cells treated with glutamate
(Figure 12). To detect the presence of active caspase subu-
nits, highly specific active caspase-3 antibody raised
against amino acids 163 to 175 (p 18 subunit) of murine
caspase-3 was obtained from Stratagene. Primary cortical
cells were treated with 1 mM glutamate for 3 and 6 h and
processed as described under "Methods". The results (Fig-
ure 12) indicate that glutamate treatment for 3 h, did not
significantly change the levels of caspase-3 active form.
However, as can be seen (Figure 12) after 6 h of glutamate
Kinetics of glutamate-induced cell death in primary cortical cells Figure 4
Kinetics of glutamate-induced cell death in primary cortical cells. Cortical cells isolated from 19 day old fetal rat 
brains were cultured for 7 days and treated with 5 mM glutamate for the indicated times in a neurobasal medium containing 2% 
antioxidant free B27. LDH release (% maximum) was measured after 3,6,8 and 24 h of treatment. Data are the mean ± SEM 
values from at least 3 experiments. *P < 0.05 compared with control ** P < 0.05 compared to 3,6,8 h control.
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treatment, the levels of caspase-3 active form increased
over 2 fold compared to untreated cells (Figure 12). These
results further confirm that caspase-3 is activated in apop-
tosis induced by glutamate in primary cortical cells.
Effects of glutamate on Fas receptor protein expression
To determine whether the regulation of caspase-3 in gluta-
mate-induced cell death in cortical cells is modulated by
Fas receptor mediated apoptotic pathway, expression of
Fas receptor protein was evaluated by Western blot
analysis. The results indicate (Figure 13) that anti-Fas
receptor antibody reacted specifically with Fas receptor
protein, however, no significant changes in the levels of
this protein were observed following treatment with vari-
ous concentrations (1–20 mM) of glutamate (Figure 13)
for up to 24 hours (Figure 14) compared to control levels.
Effects of glutamate and estrogen on the release of 
mitochondrial cytochrome c into the cytosol
To determine whether the activation of caspase-3 in gluta-
mate-induced cell death requires cytochrome c, primary
cultures of cortical cells were first incubated with 1 mM
glutamate for up to 6 hours. The cells were then processed
for Western blot analysis as described under "Methods".
The results depicted in Figure 15 clearly indicate that prior
to glutamate treatment, the bulk of cytochrome c is
localized in the mitochondria and barely detectable levels
were observed in the cytosol. In contrast, exposure of cells
Effect of various concentrations of 17β -E2 and ∆ 8, 17β -E2 on glutamate (5 mM) induced cell death in primary cortical cells Figure 5
Effect of various concentrations of 17β -E2 and ∆ 8, 17β -E2 on glutamate (5 mM) induced cell death in primary 
cortical cells. Cortical cells isolated from 19 day old fetal rat brains were cultured for 7 days and treated with 5 mM gluta-
mate alone or in the presence of estrogens in neurobasal medium containing 2% antioxidant free B27. LDH release (% maxi-
mum) was measured after 6 h treatment. Data are the mean ± SEM values from at least 3 experiments. a = P < 0.05 compared 
with untreated control cells; b = P < 0.05 compared with glutamate alone.
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to glutamate resulted in a rapid release of cytochrome c
from the mitochondria into the cytosol (Figure 15). Sig-
nificant increase in cytosolic cytochrome c occurred as
early as 1.5 h, and after 3 h, the levels of cytochrome c
were higher in the cytosol compared to the mitochondria
(Figure 15). By 6 h, the levels of cytochrome c in the
cytosol were 2.5 times higher than those in the mitochon-
dria. The cytosolic levels of cytochrome c between 1.5
hours to 6 hours were 2 to 5 fold higher in the cytosol pre-
pared from glutamate treated cells compared to untreated
cells (Figure 15). Concomitant with these changes in the
cytosol, the mitochondrial levels of cytochrome c
decreased significantly. Similar results were also observed
when 5 mM glutamate was used (data not shown). Expo-
sure of cortical cells to 1 mM glutamate and 1 µM 17β -E2
or ∆ 8, 17β -E2 for 6 hours resulted in a significant decrease
in the release of cytochrome c into the cytosol (Figure 16).
Thus, the levels of cytochrome c in the cytosol from estro-
gen-treated cells were 30 to 50% lower than the corre-
sponding levels in the glutamate alone treated cells
(Figure 16).
Discussion
In the present study, we used primary fetal rat cortical cell
cultures to demonstrate that glutamate can induce neuro-
nal cell death by apoptotic mechanisms and that the proc-
ess can be reversed or inhibited by equine estrogens such
as 17β -E2 and ∆ 8, 17β -E2. Our results further indicate that
glutamate-induced cell death appears to result, to some
extent, by a mechanism that involves DNA fragmentation
Effects of various concentrations of glutamate on caspase-3 protein levels in primary cortical cells Figure 6
Effects of various concentrations of glutamate on caspase-3 protein levels in primary cortical cells. Cortical cells 
isolated from 19 day old fetal rat brains were cultured for 7 days and treated with 1,5,10 and 20 mM glutamate for 6 h in a neu-
robasal medium containing 2% antioxidant free B27. Cells were then harvested and total protein was extracted. Caspase-3 
protein levels were assessed by Western blot analysis as described under "Methods". Actin was used as loading control. The 
bars depict densitometric analyses of Western blots from at least three experiments (± SEM). *P < 0.05 compared with 
untreated control cells.
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and morphological changes characteristic of apoptosis.
These changes are similar to those we and others have
reported previously with other neuronal cell models
[7,13]. Unlike the mouse hippocampal cell line HT22
[13], the primary cultures of rat cortical cells after day two
in culture appear to undergo some degree of apoptotic cell
death in absence of glutamate (Figure 2), however, the
extent of DNA fragmentation is significantly enhanced
after treatment with glutamate. Moreover, compared to
the HT22 cells, the primary rat cortical cells appear to be
resistant and require higher concentration of glutamate to
induce apoptosis. Similar differences were also observed
between HT22 cells and PC12-neuronal cells derived from
rat adrenal pheochromocytoma [31]. The glutamate
induced DNA fragmentation and subsequent cell death
was associated with characteristic morphological changes
also noted previously in HT22 cells following treatment
with β -amyloid and glutamate [13,37]. The results from
the present study indicate that these morphological
changes associated with apoptosis were prevented by 17β -
E2 and ∆ 8, 17β -E2 (Figure 3). To quantitatively estimate
the extent of cell death induced by glutamate, we meas-
ured cell viability by MTS assay and cell death by LDH
activity released in the media during culture. Results from
the MTS assay clearly indicated that cell viability was
dependent on the dose of glutamate (Figure 1). Thus,
increasing concentrations of glutamate resulted in a dose-
dependent decrease in cell viability. Because in the MTS
proliferation assay, cells cannot be reused, subsequent
Kinetics of glutamate (5 mM) treatment on caspase-3 protein levels in primary cortical cells Figure 7
Kinetics of glutamate (5 mM) treatment on caspase-3 protein levels in primary cortical cells. Cortical cells iso-
lated from 19 day old fetal rat brains were cultured for 7 days and treated with 5 mM glutamate for the indicated times in a 
neurobasal medium containing 2% antioxidant free B27. Cells were then collected and total protein was extracted. Caspase-3 
protein levels were determined by Western blot analysis as described in Figure 6. The bars depict densitometric analyses of 
Western blots from at least three experiments (± SEM). *P < 0.05 compared to untreated control cells.
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quantitative experiments were carried out using LDH
release assay. The LDH assay had previously been vali-
dated using the MTS assay [29,31].
In the present study, we further observed that glutamate
induces cell death of primary rat cortical cells and involves
changes in caspase-3 protease. Exposure to glutamate up-
regulated caspase-3 protein levels while caspase inhibitors
blocked this apoptotic process. These observations indi-
cated that cell death induced by glutamate in primary cor-
tical neurons was via apoptosis.
Caspase-3 was one of the cysteine proteases that played an
essential role in apoptosis by cleaving several key cellular
proteins such as poly (ADP-ribose) polymerase (PARP),
sterol-regulatory element-binding protein (SREBPs), PKC,
DNA-dependent protein kinase, DNA-fragmentation fac-
tor (DFF) and a number of others [16,19,21,24,25,35,36].
Our studies show that up-regulation of caspase-3 expres-
sion preceded neuronal cell death, supporting the possi-
bility that glutamate-induced apoptotic cell death was the
consequence of up-regulation of caspase-3 gene in cortical
neurons. These observations are consistent with up-regu-
lation of precursor caspase-3 in frontal neuronal cortex of
subjects with Alzheimer's disease [5]. This enzyme has
been proposed to activate death effector molecules result-
ing in the fragmentation of genomic DNA and was
Effects of estrogens on caspase-3 protein levels during glutamate (5 mM) induced cell death in primary cortical cells Figure 8
Effects of estrogens on caspase-3 protein levels during glutamate (5 mM) induced cell death in primary cortical 
cells. Cortical cells isolated from 19 day old fetal rat brains were cultured for 7 days and treated with 5 mM glutamate alone 
or in the presence of 17β -E2 and ∆ 8, 17β -E2 for 6 h. Cells were then harvested and total protein was extracted. Caspase-3 pro-
tein levels were determined by Western blot analysis as described under Figure 6. The bars depict densitometric analyses of 
Western blots from at least three experiments (± SEM). a = P < 0.05 compared with untreated control cells, b = P < 0.05 com-
pared with glutamate alone.
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associated with morphological and structural changes
characteristic of apoptosis [16,19,21,25,38].
When cells undergo apoptosis, caspase-3 is initially
present as pro-enzyme (32 kDa precursor protein) that is
subsequently transformed into the active heterodimeric
complexes through a cascade of proteolytic events
[14,18]. The active form of caspase-3 is composed of two
subunits of Mr 20 kDa (p20) and 11 kDa (p11), which are
derived from proteolytic processing of the 32 kDa precur-
sor during apoptosis [21,24,25]. In our study, these p 20
and p11 forms of caspase-3 were not detected in
glutamate-induced cell death by immunoblotting analysis
with three different kinds of antibodies: i. a polyclonal
goat antibody caspase-3 p11 (K-19) against the p11 frag-
ment of caspase-3, ii. a polyclonal rabbit antibody against
caspase-3 (H-227) and iii. a monoclonal mouse antibody
(E-8) (data not shown with this latter antibody). These
observations suggest that either our antibodies are incapa-
ble of detecting these fragments or that cells may clear
them rapidly as been observed in other studies [39]. Since
we observed that glutamate-induced cell death was effec-
tively blocked by both caspase-3 specific inhibitor z-
DEVD and pan-caspase-inhibitor z-VAD, these data fur-
ther provide evidence that caspase-3 protease is not only
up-regulated, but is also activated during glutamate-
Effects of estrogens on caspase-3 protein levels during glutamate (1 mM) induced cell death in primary cortical cells Figure 9
Effects of estrogens on caspase-3 protein levels during glutamate (1 mM) induced cell death in primary cortical 
cells. Cortical cells isolated from 19 day old fetal rat brains were cultured for 7 days and treated with 1 mM glutamate alone 
or in the presence of 17β -E2 and ∆ 8, 17β -E2 for 6 h. Cells were then harvested and total protein was extracted. Caspase-3 pro-
tein levels were determined by Western blot analysis as described under Figure 6. The bars depict densitometric analyses of 
Western blots from at least three experiments (± SEM). a = P < 0.05 compared with untreated control cells, b = P < 0.05 com-
pared with glutamate alone.
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induced cell death. That activation of pro-caspase-3 does
indeed occur in glutamate-induced apoptotic cell death of
primary rat cortical cells was confirmed by the
demonstration that PKC, an endogenenous substrate of
active caspase-3, was cleaved into two 45 kDa and 48 kDa
BDPs [35,36]. The formation of these BDPs is characteris-
tic of caspase-3 like protease activity [35,36]. The forma-
tion of the two BDPs was inhibited by caspase-3 specific
inibitor z-DEVD and pan-caspase-inhibitor z-VAD). These
results strongly suggest that proleolytic cleavage of PKC
involves active caspase-3. These observations were further
supported by the direct immunodetection of activated
caspase-3 in the primary cultures of rat cortical cells
treated with glutamate (Figure 12). The primary antibody
was raised against amino acids 163 to 175 of murine cas-
pase-3 and this neo-epitope is present on the p18 subunit
of cleaved caspase-3. This antibody recognizes the p18
subunit but not the inactive pro-caspase-3 [40]. Taken
together these data strongly indicate that in our neuronal
cell cultures, glutamate induces apoptosis that involves
active caspase-3. In contrast, it has been suggested that
glutamate-induced cell death in HT22 mouse hippocam-
pal cells appears to occur by apoptotic mechanisms that
are independent of caspase-3 [13]. Since in HT22 cells,
glutamate also induced DNA laddering, mitochondrial
proteins such as apoptosis inducing factor (AIF) and
Effects of caspase inhibitors on glutamate-induced cell death in primary cortical cells Figure 10
Effects of caspase inhibitors on glutamate-induced cell death in primary cortical cells. Cortical cells isolated from 
19 day old fetal rat brains were cultured for 7 days. Cell death was measured by LDH release assay 6 h after incubation with 1 
mM glutamate with or without 30 min pretreatment with 100 µM caspase-3 specific inhibitor z-DEVD or a pan-caspase inhibi-
tor z-VAD (A,B,C and D). Inhibitors alone (E and F) or DMSO (G) had not effect on LDH release. Data are the mean ± SEM 
for 3 experiments performed. a = P < 0.05 compared with control, b = P < 0.05 compared with glutamate alone.
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endonuclease G (Endo G) released in response to death
signals may also play a role in the HT22 neuronal cell line
[13]. Whether similar caspase-3 independent pathways
are also involved in glutamate-induced apoptosis in pri-
mary cultures of rat cortical cells remains to be
investigated.
Several signaling pathways are implicated in the initiation
of the caspase-3 cascade; one of the well defined pathways
for activation of apoptosis is Fas receptor-mediated path-
way [41-43]. Fas is a cell surface antigen and a member of
tumor necrosis factor (TNF) receptor family [44].
Activation of Fas by its ligand or an agonistic anti-Fas anti-
body can transmit apoptotic signal by activation of cas-
pase-3 and induces apoptosis in T-lymphocytes and
malignant cells [26,45,46]. In vitro, cross-linking of Fas
antibody to its antigen increases caspase-3 activity and
induces apoptotic cell death in Jurkat cells [47]. However,
in primary cortical cells, we did not observe any change in
Fas receptor protein levels following glutamate treatment.
These results suggest that activation of caspase-3 in neuro-
nal cortical cells and their apoptotic demise induced by
glutamate is independent of Fas receptor mediated path-
way. However, the Fas mediated pathway is complex and
further studies are required to establish whether this path-
way is or not involved in glutamate-induced cell death in
cortical cells. In contrast to glutamate, chronic morphine
administration has been shown to induce up-regulation
of Fas receptor and caspase-3 precursor protein in the rat
neuronal cells [48,49]. Thus, whether Fas receptor medi-
ated pathway plays a role in up-regulation of caspase pro-
tein or caspase-3 activation and apoptotic cell death may
depend on the nature of neurotoxic agents being used.
Another recently characterized mechanism for pro-cas-
pase-3 activation involves translocation of the respiratory
chain protein, cytochrome c (Apaf-2), from mitochondria
to the cytosol during the induction of apoptosis by a
variety of different agents in non-neuronal and neuronal
cells such as cerebellar granule cells [21,50]. Cytosolic
cytochrome c binds to Apaf-1 in the presence of dATP and
this leads to the recruitment and activation of caspase-9
and subsequent activation of caspase-3 [23,25]. In mito-
chondria cytochrome c resides in the inter-membrane
Effect of caspase inhibitors on proteolytic cleavage of PKC in primary cortical cells treated with glutamate Figure 11
Effect of caspase inhibitors on proteolytic cleavage of PKC in primary cortical cells treated with glutamate. Pri-
mary cortical cells were cultured for 7 days and then treated with 1 mM glutamate with or without 30 minutes of pre-treat-
ment with 100 µM caspase-3 specific inhibitor z-DEVD or a pan-caspase inhibitor z-VAD. After 6 h cells were harvested and 
total protein was extracted from the cytosol and cell lysates. PKC and its fragments were assessed by Western blot analysis as 
described under "Methods". Immunoblots indicate the presence of PKC (80 kDa) and its 48 kDa and 45 kDa breakdown prod-
ucts (BDPs). Note that glutamate treatment results in the formation of greater amounts of the 2 BDPs (lanes 2 and 4) in the 
cytosol and cell lysates compared to the untreated controls (lanes 1 and 3). Pre-treatment of cortical cells with 100 µM z-
DEVD or z-VAD prior to glutamate inhibits the formation of PKC to its BDPs to levels seen in untreated control cells (lanes 
7,8).
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space and matrix as a soluble protein and it functions as
an electron carrier in oxidative phosphorylation [21]. The
mechanism responsible for the translocation of cyto-
chrome c from mitochondria into cytosol is not known.
Cytochrome c release can occur upon interaction of pro-
apoptotic protein with the outer mitochondria membrane
protein such as Bax [51,52] or can be induced by interac-
tion with elevated calcium or reactive oxygen species
(ROS) with mitochondria. This results in mitochondrial
dysfunction and a reduction in mitochondrial trans-mem-
brane potential [53-55]. Our present studies demonstrate
that glutamate-induced cell death in primary cortical cells
is accompanied by the early release of cytochrome c into
the cytoplasm that precedes changes in caspase-3 pro-
tease. Although we were unable to directly detect by West-
ern blot analysis, the active caspase-3 fragments p20 and
p11, the presence of active caspase-3 was confirmed as dis-
cussed above. Since there was a close correlation between
the time course of cytochrome c release from the mito-
chrondria and changes in caspase-3 protease levels; it pro-
vides a possible mechanism whereby caspase-3 protease is
not only up-regulated, but also activated by cytochrome c
during glutamate-induced apoptotic cell death of primary
cortical cells. Whether cytochrome c release from the
mitochondria to cytosol is involved in the regulation of
caspase-3, remains to be investigated.
We have previously reported that a number of equine
estrogens, which are components of the drug CEE (conju-
gated equine estrogen) used extensively for management
of vasomotor symptoms and osteoporosis in postmeno-
pausal women, are potent antioxidants and protect
neuronal cells against cell death induced by oxidized LDL
and glutamate [28,29,56,57]. In keeping with these obser-
vations, the results from the present study indicate that in
primary cortical cells, these equine estrogens prevent cell
death by reducing glutamate-induced cytochrome c
release from mitochondria and caspase-3 protein levels.
To our knowledge, this is the first study that demonstrates
that equine estrogens can prevent glutamate-induced
translocation of cytochrome c from mitochondria to the
cytosol in the rat primary cortical cells. Previous studies
have shown that 17β -E2 induces release of cytochrome c
from heart mitochondria [58] and also decreases cytosolic
cytochrome c levels in hippocampus following global
ischemia [59]. These observations indicate that equine
estrogens protect against glutamate-induced apoptosis of
primary cortical cells at least in part by inhibiting caspase-
Detection of active caspase-3 by immunofluorescence Figure 12
Detection of active caspase-3 by immunofluorescence. Primary cortical cells were cultured for 7 days in 96-well micro-
plates and then treated with or without 1 mM glutamate for 3 h and 6 h. The cells were fixed and then incubated first with pri-
mary rabbit anti-cleaved caspase-3 antibody and then with FITC-goat anti-rabbit secondary antibody as described under 
"Methods". After aspiration, the cells were washed twice with PBS + saponin and the relative fluorescence measured using a 
Labsystem Fluroskan Accent FL microplate reader (excitation 490 nm; 520 nm emission). The bars depict relative fluorescence 
units from 3 measurements (± SEM). P < 0.05 compared to control untreated cells.
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dependent apoptotic pathway. However, the mechanism
by means of which estrogens reduce cytochrome c release
from mitochondria is not yet fully understood. Some have
suggested that the mechanism of estrogen-mediated neu-
roprotection involves regulation of mitochondrial cal-
cium (Ca2+) and Bcl-2 expression [59]. Exposure of
glutamate has also been associated with an increase of
cytosolic Ca2+ in cortical cells [3,53] and up-regulation of
pro-apoptotic protein Bax in neuronal cell line, HT22
[13]. Whether these changes induced by glutamate are
involved in the mitochondria release of cytochrome c into
the cytosol, remains to be investigated.
The cortical neuronal cells used in the present study con-
tain both estrogen receptors ERα  and ERβ  (Bhavnani and
Zhang, unpublished data), and therefore whether the
mechanism by means of which estrogens exert their neu-
roprotective effects remain to be elucidated. In general,
the current evidence indicates that there are at least two
mechanisms for estrogen action: i) the genomic mecha-
nism mediated via two nuclear receptors ERα  and ERβ ,
and ii) the non-genomic mechanism mediated via puta-
tive membrane receptors and these have been recently
reviewed [32]. Although the concentrations of estrogens
that protect the cortical neurons from glutamate toxicity
are pharmacological doses, these levels can however, be
potentially attained in a postmenopausal women taking
daily 0.625 mg of (CEE) [61]. These estrogen effects are
most-likely mediated to some extent by the non-genomic
mechanism, and may be related to the estrogens'
Effects of various concentration of glutamate on Fas receptor protein levels in primary cortical cells Figure 13
Effects of various concentration of glutamate on Fas receptor protein levels in primary cortical cells. Cortical 
cells isolated from 19 day old fetal rat brains were cultured for 7 days and treated with 1,5,10 and 20 mM glutamate for 6 h. 
Cells were harvested and total protein was extracted. Fas receptor protein levels were assessed by Western blot analysis as 
described under Figure 6. The results show that glutamate had no significant effect on Fas receptors. Data are the mean (± 
SEM) from 3 experiments.
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antioxidant property [28,29]. This is in keeping with our
previous observations that although 17β -E2 has higher
affinity for ERα  and ERβ , it is possible that some of these
effects are due to the antioxidant properties of estrogens.
However, we have also demonstrated [33] that ∆ 8, 17β -E2
expresses its biological effects to a two fold greater extent
via ERβ  than 17β -E2 [33]. Since the localization of ERα
and ERβ  in the brain is differential [[32] and references
therein] further detailed studies are needed to elucidate
the molecular mechanisms involved in the neuroprotec-
tive aspects of estrogens.
Recent studies further report that estrogen receptor (ERβ )
is localized in the mitochondrial membrane and estrogen
can directly modulate the mitochondrial content of Ca2+
and mitochondrial trans-membrane potential [61,62].
The role of the novel estrogen membrane receptors in
apoptotic cell death induced by glutamate remains to be
investigated. We along with others, have previously dem-
onstrated that estrogens prevent cell death induced by
glutamate [13] or β -amyloid [63] via modulation of Bcl-2
family of proteins. Thus, it is possible that in the neuronal
cell model, estrogens decrease glutamate-induced cyto-
chrome c release from mitochondria by protecting mito-
chondrial trans-membrane potential via binding estrogen
receptor on mitochondrial membrane as well as up-regu-
lation of anti-apoptotic protein Bcl-2. Studies to further
delineate these mechanisms are being initiated.
Kinetics of glutamate (5 mM) treatment on Fas protein levels in primary cortical cells Figure 14
Kinetics of glutamate (5 mM) treatment on Fas protein levels in primary cortical cells. Cortical cells isolated from 
19 day old fetal rat brains were cultured for 7 days and treated with 5 mM glutamate for the indicated times. Cells were col-
lected and total protein was extracted. Fas receptor protein levels were determined by Western blot analysis as described 
under Figure 6. The results show that glutamate has no significant effects on Fas receptors up to 24 h of treatment. Data are 
the mean (± SEM) from 3 experiments.
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Conclusion
In the primary cortical cells, glutamate-induced apoptosis
is accompanied by up-regulation of caspase-3 that can be
blocked by caspase protease inhibitors. These effects of
glutamate on caspase-3 appear to be independent of
changes in Fas receptor, but are associated with the rapid
release of mitochondrial cytochrome c, which precedes
changes of caspase-3 protein levels leading to apoptotic
cell death. This process was differentially inhibited by
estrogens with the novel equine estrogen ∆ 8, 17β -E2 being
more potent than 17β -E2, To our knowledge, this is the
first study to demonstrate that equine estrogens can pre-
vent glutamate-induced translocation of cytochrome c
from mitochondria to cytosol in rat primary cortical cells.
Methods
Materials
All primary and secondary antibodies and other reagents
were purchased from commercial sources: rabbit polyclo-
nal antibody to caspase-3 (H-227: sc 7148) and goat
polyclonal antibody to caspase-3 p11 (K-19: sc-1224).
Both of these antibodies react specifically with precursor
protein: Mr 32 kDa and the active caspase-3: Mr 20 (p 20)
and 11 kDa (p 11) fragments. Rabbit polyclonal antibody
Kinetics of glutamate (1 mM) induced Cyto c release from mitochondria into cytosol in primary cortical cells Figure 15
Kinetics of glutamate (1 mM) induced Cyto c release from mitochondria into cytosol in primary cortical cells. 
Primary cortical cells isolated from 19 day old fetal rat brains were cultured for 7 days and then treated with 1 mM glutamate 
for the indicated times. Mitochondrial and cytosol fractions were isolated as described in "Methods". Protein levels of Cyto c in 
mitochondria and cytosol were determined by Western Blot analysis as described under Figure 6. Actin bands were also used 
to monitor the same blot to verify consistency of cytosolic protein loading. The content of Cyto c was measured by densito-
metric scanning of the film. The results are the mean (± SEM) of at least three experiments. *P < 0.05 compared with control.
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to protein kinase c (P4334) (PKC, crossreacts with PKCα
/and PKC δ ) purchased from Sigma. Goat polyclonal anti-
body to Actin (I-19: sc1616) (all from Santa Cruz, Califor-
nia), mouse monoclonal antibody to Fas raised against
Fas extracellular domain (CD95:AF435) (R&D System,
Inc. Minnepolis, MN), mouse monoclonal antibody cyto-
chrome c (7H8.2C12) (BD PharMingen, Mississauga,
ON). Secondary antibodies were obtained from Sigma
(Saint Louis, Missouri). SuperSignal®  West Pico
Chemiluminescent Substrate (Pierce, Rockford, IL). Z-Val-
Ala-DL-Asp (OMe)-fluoromethylketone (z-VAD-fmk)
and z-Asp (OMe)-Glu (OMe)-Val-DL-Asp (OMe)- fluor-
omethylketone (z-DEVD-fmk) (Bachem Bioscience Inc.,
King of Prussia, PA) and the Cytotox 96 Non-radioactive
Cytotoxicity Assay Kit (Promega G1780, from VWR,
Toronto, Ontario, Canada). Neurobasal, B27, Hanks'
buffered salt solution (HBSS) and antibiotics were from
Gibco Life technologies (Burlington, Ontario, Canada).
Active Caspase-3 Detection FITC kit # 280000 was
obtained from Stratagene (La Jolla, CA).
Animals
Timed pregnant Sprague-Dawley rats were obtained from
commercial sources. All procedures were reviewed and
Effects of 17β -E2 and ∆ 8, 17β -E2 on glutamate-induced Cyto c release into cytosol in primary cortical cells Figure 16
Effects of 17β -E2 and ∆ 8, 17β -E2 on glutamate-induced Cyto c release into cytosol in primary cortical cells. Pri-
mary cortical cells isolated from 19 day old fetal rat brains were cultured for 7 days and treated with 1 mM glutamate alone or 
in the presence of 17β -E2 and ∆ 8, 17β -E2. After 6 h, cells were collected and cytosol fraction was prepared as described under 
"Methods". Cytosolic protein levels of Cyto c were determined by Western blot analysis as described under Figure 6. Actin 
bands were used to monitor the same blot to verify consistency of protein loading. The content of Cyto c was measured by 
densitometric scanning of the film. The results are the mean (± SEM) of at least three experiments. a = P < 0.05 compared with 
control; b = P < 0.05 compared with glutamate treated cells.
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approved by the Institutional Animal Care and Use Com-
mittee at St. Michael's Hospital, University of Toronto, in
accordance with the guidelines of the Canadian Council
on Animal Care.
Cell culture
Eighteen to twenty day old pregnant Sprague-Dawley rats
were sacrificed by cervical dislocation. The fetuses were
delivered and fetal skulls were carefully opened and the
meninges were removed and the brain processed
essentially as described by Brewer et al. [64]. Briefly, two
pieces of cortex (0.5–1.5 × 1–2 mm) were cut from the
posterior dorsal surface and dissociated in HBSS (Ca2+
and Mg2+ free). Following dissociation, cells were sus-
pended in 2 X volume of HBSS with Ca2+ and Mg2+ and
allowed to settle for 3 to 5 minutes. The supernatant was
transferred to new tubes and centrifuged at 1100 rpm
(200 g) for 1 min. The pellets were suspended in HBSS
buffer. Fresh cell suspensions were plated onto poly-L-
lysine-coated 96-well plates or 6-well plates containing
neurobasal medium supplemented with 2% B27, 0.5 mM
L-glutamine, 25 µM glutamic acid, 120 mg/L penicillin
and 260 mg/L streptomycin and incubated at 37 C in a
humidified incubator with 5% CO2/95% air. Culture
medium was replaced every other day. Experiments were
performed on days 7 to 8 of cultures in neurobasal
medium containing 2% antioxidant free B27 supplement.
Under these serum-free culture conditions, only neuronal
cells survive.
Determination of glutamate-Induced cell cytotoxicity
During the development of this work, the lactate dehydro-
genase (LDH) cytotoxicity assay (Promega G1780, VWR
Toronto, Ontario, Canada) and the Cell Titer 96® Aqueous
Non-radioactive cell proliferation assay (MTS assay,
Promega G5430) were used to assess cell death and cell
viability respectively [31]. In MTS (3-[4,5-dimethylthia-
zol-2 yl]-5 [3-carboxymethoxyphenyl]-2H-tetrazolium,
inner salt) the formation of a formazan product occurs
only in live cells, however, once treated with MTS, the
cells are not useable for other measurements. We have
previously demonstrated [31] a strong correlation
between the MTS and LDH assays [31]. Since we wanted
to use the cells for various determinations, the LDH assay
for cell death was selected as in this assay only the
supernatant is used and the cells can be used for other
measurements. Thus after the initial determination of the
glutamate dose response curve, only the LDH assay was
used in all subsequent experiments. Cell death was meas-
ured by the Cytotox 96 Assay kit, which quantitatively
measures the release of lactate dehydrogenase into the
medium following cell lysis or cell death as described pre-
viously [13]. In all experiments, cultures were also treated
with 0.1% Triton X-100 to lyse the cells, and LDH levels
measured under these conditions, were taken as the max-
imal LDH release (100% cell death). The results were
expressed as a percentage of maximum LDH release.
Assessment of apoptosis by DNA fragmentation
Apoptotic cells produce characteristic DNA ladders made
up of nucleotide fragments which are visualized by stain-
ing with ethidium bromide following DNA-agarose gel
electrophoresis. We used DNA fragmentation as one of
the criteria for apoptotic cell death and this was deter-
mined as described previously [13]. Briefly, primary corti-
cal cells isolated from 18 to 20 day old fetal rat brains were
cultured for up to 7 days and then treated with 1 mM
glutamate for 18 h. The cell monolayers were washed with
ice cold TBS (20 mM Tris-HCl, pH 7.6, 137 mM NaCl)
and then DNA was isolated as described previously [13].
The DNA (5 µg) was electrophoresed on 1.5% agarose gel
for 1.5 h at 100 V. The DNA fragments were visualized by
staining with ethidium bromide and detected under UV
transillumination.
Western blot analysis
Protein levels of Caspase-3, Fas or PKC were determined
by Western blotting using a polyclonal and monoclonal
antibody raised against caspase-3 or Fas or PKC as
described previously [13]. In brief, cells were washed
twice with cold PBS, harvested using a cell scraper, and
lysed in buffer (9 mM Na2PO4, 1.7 mM NaHPO4 150 mM
NaCl, pH 7.4), containing 1% Nonidet P-40 (Sigma,
Toronto, Canada), 0.5% sodium deoxycholate, 0.1% SDS
and 1 mM phenyl methyl sulfonyl fluoride) for 20 min on
ice. Cell lysates were centrifuged at 10,000 g at 4 C for 10
min. The protein concentration was determined by Brad-
ford method (BioRad, Toronto, Canada). Cell lysates con-
taining 10 to 20 µg protein were added in equal volume
of 2 X reducing sample buffer (100 mM Tris-CI pH 6.8,
200 mM dithiothretiol, 4% SDS, 20% glycerol, and 0.2%
Bromophenol blue) and heated at 100 C for 3 min. The
samples were electrophoresed on discontinuous 10%
polyacrylamide gel electrophoresis under constant current
(14–15 mA). Separated proteins were electrotransfered
onto a Protan nitrocellulose membrane (Schleicher &
Schuell Inc., Keene N.H). The blots were blocked with 5%
non-fat milk in TBST (20 mM Tris-HCl pH 7.6, 137 mM
NaCl, 0.05% Tween-20) at 4 C overnight and then incu-
bated with primary antibody for 1 to 2 h at room
temperature, washed three times with TBST and incubated
(1–2 h) with appropriate horse radish peroxidase (HRP)-
conjugated second antibody. The membranes were
washed three times with TBST and the immunoblots were
visualized on X-ray films after exposure to enhanced
chemiluminescence reagent (ECL) (Amersham, Toronto,
Canada). Actin bands were monitored on the same blot to
verify consistency of protein loading. Briefly, the Immu-
noblots were stripped with TBST containing 0.04%
sodium azide for 30 min at room temperature. The blotsBMC Neuroscience 2005, 6:13 http://www.biomedcentral.com/1471-2202/6/13
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were probed with anti-actin primary antibody and second
antibody (anti-goat) as described above. The molecular
size of protein was determined by running pre-stained
protein markers in an adjacent lane, omitting primary
antibody as a procedural control. The band intensity was
measured from scanned images using UN-SCAN IT Gel
Automated Digitizing system, Version 5.1 (Silk scientific,
Inc, Orem, Utah, USA), software.
Statistics
Each experiment was repeated at least three times and
combined data were compared using the Student's paired
t- test. Analysis of variance (ANOVA) when appropriate,
was used for multiple comparisons. Significance was set at
P < 0.05.
Measurement of cytochrome c translocation
The cell homogenates, mitochondria and cytosolic frac-
tions were prepared essentially as described by Atlante et
al. [54]. The cells were washed twice with ice-cold PBS, pH
7.4 and then suspended in cold isotonic buffer (250 mM
sucrose, 20 mM Hepes-KOH, 10 mM KCI, 1.5 mM MgCI2,
1 mM Na-EDTA, 1 mM Na-EGTA, 1 mM dithiothretiol
and protease inhibitors-complete cocktail). After 15 min
incubation on ice, cells were homogenized using a glass
homogenizer (25 stokes) at 4 C. Cell homogenates were
spun at 750 g for 10 minutes and the pellets containing
the nuclei and unbroken cells were discarded. The super-
natant was then centrifuged at 10,000 g for 15 minutes.
The pellets containing mitochondria was stored at -80 C
until processed. The 10,000 supernatant was further cen-
trifuged at 100,000 g for 1 hour at 4 C to obtain the
cytosolic fraction (S-100). The intactness of the
mitochondrial membranes was checked by assaying mito-
chondrial specific enzyme glutamate dehydrogenase in
mitochondria, mitochondria treated with Triton X-100
and in cytosol (S-100) as described previously [54]. GDH
was only detectable in mitochondria and mitochondria
treated with Triton X-100. It was undetectable in cytosol.
Thus, the cytosol fraction was free of mitochondrial con-
tamination. Following analysis of protein concentration,
the levels of cytochrome c in these two fractions were ana-
lyzed by Western blot on 12% SDS-polyacrylamide gel.
Cytochrome c was detected using murine anti-cytochrome
c antibody as described above.
Assessment of the effects of caspase inhibitors
Caspase inhibitors were used as described previously [65]
caspase-3-inhibitor z-DEVD-fmk and a pan-caspase-
inhibitor z-VAD-fmk. The concentrations of inhibitors
tested were 25, 50 and 100 µM. Both were prepared as 20
mM stocks in DMSO and stored at -80 C. Primary cultures
were incubated with the inhibitors for 30 min prior to the
addition of glutamate. Effects of inhibitors on glutamate-
induced cell death were measured with LDH release assay
as described above.
Detection of active caspase-3 by immunofluorescence
The primary cortical cells were cultured for 7 days in 96-
well microplates and then treated with or without gluta-
mate for 3 h and 6 h. Cells were then processed essentially
as described by the manufacturer of the assay kit (Strata-
gene). Briefly, the microplates were centrifuged (200 × g)
for 2 minutes and the supernatant discarded. The cells
were fixed for 15 minutes following which the fixative was
aspirated and the cells washed twice with phosphate buff-
ered saline (PBS) containing 1% saponin. The cells were
then incubated with the primary anti-cleaved caspase-3
antibody in PBS + 1% saponin for 30 minutes at room
temperature. The cells were then rewashed and incubated
for 30 minutes with secondary FITC-goat anti-rabbit
antibody and then washed twice and the relative fluores-
cence measured using a microplate reader (excitation 490
nm; emission 520 nm).
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